9 terminated. 9 Phase 2, 1 Phase 3.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 9 | Terminated 9 |
| Phase 3 | 1 | Terminated 1 |
Follow Social Behavior: new trials by email Literature Review of Social Behavior trials Research Report on Social Behavior
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Starting the Conversation STC - Stigma of Parents of Children With Mental Illness | Phase 2 | Terminated | University of Ulm | 5 | 2019-10-01 | 2021-05-07 |
| To Share Or Not To Share 2Share - History of Suicide Attempt | Phase 2 | Terminated | University of Ulm | 4 | 2019-05-07 | 2020-03-13 |
| A Study of MP-101 in Dementia-Related Psychosis and/or Agitation and Aggression MP-101, Placebo - Psychosis, Dementia | Phase 2 | Terminated | Mediti Pharma Inc. | 81 | 2017-05-04 | 2021-04-01 |
| Oxytocin in Adolescents With Autism Spectrum Disorders OCYTOCINA - SPRAY NASAL - Autism Spectrum Disorder | Phase 2 / Phase 3 | Terminated | University of Sao Paulo General Hospital | 30 | 2015-06-01 | 2019-10-28 |
| Efficacy and Safety of Eculizumab for Treatment of Antibody-mediated Rejection Following Renal Transplantation Eculizumab, Immunoglobulin, Plasmapheresis - Antibody-mediated Rejection, Humoral Rejection | Phase 2 | Terminated | Brigham and Women's Hospital | 11 | 2013-11-01 | 2017-09-21 |
| A 36-Week Safety Extension Study of ELND005 as a Treatment for Agitation and Aggression in Alzheimer's Disease Group 1 ELND005, Group 2 ELND005 - Alzheimer's Disease | Phase 2 | Terminated | OPKO Health, Inc. | 296 | 2013-01-01 | 2019-10-21 |
| A Clinical Trial to Determine the Effect of Lutropin Alfa on Embryo Quality and Implantation Rate in Advanced Reproductive Age Recombinant human luteinizing hormone (rhLH), Recombinant follicle-stimulating hormone (rFSH) - Infertility, Ovulation Induction | Phase 2 | Terminated | Merck KGaA, Darmstadt, Germany | 76 | 2008-11-01 | 2014-02-13 |
| A Phase II Study to Assess the Efficacy and Safety of LuverisĀ® (Lutropin Alfa) in Mid Follicular Phase for Controlled Ovarian Stimulation (COS) in Advanced Reproductive Age r-hLH + r-hFSH, r-hFSH, Recombinant Human Choriogonadotropin (r-hCG) - Infertility, Ovulation Induction | Phase 2 | Terminated | Merck KGaA, Darmstadt, Germany | 93 | 2007-11-01 | 2014-02-27 |
| 24 Month Extension to Efficacy and Safety of AEB071 Plus Tacrolimus (Converted to Mycophenolic Acid After 3 Months) in Renal Transplant Patients(Converted to Mycophenolic Acid After 3 Months) in Renal Transplant Patients AEB071, mycophenolic plus tacrolimus - Kidney Transplantation | Phase 2 | Terminated | Novartis Pharmaceuticals | 137 | 2007-10-01 | 2020-12-17 |
Aggression (2) · Alzheimer Disease (2) · Helping Behavior (2) · Infertility (2) · Psychomotor Agitation (2) · Rejection, Psychology (2) · Social Stigma (2) · Autism Spectrum Disorder (1) · Autistic Disorder (1) · Dementia (1) · Psychotic Disorders (1) · Social Skills (1)
Behavior (9) · Mental Disorders (3) · Aberrant Motor Behavior in Dementia (2) · Behavioral Symptoms (2) · Brain Diseases (2) · Central Nervous System Diseases (2) · Dyskinesias (2) · Genital Diseases (2) · Nervous System Diseases (2) · Neurobehavioral Manifestations (2) · Neurocognitive Disorders (2) · Neurodegenerative Diseases (2) · Neurologic Manifestations (2) · Pathological Conditions, Signs and Symptoms (2)
Luteinizing Hormone, beta Subunit (2) · Chorionic Gonadotropin (1) · Glycoprotein Hormones, alpha Subunit (1) · Immunoglobulins (1) · Immunoglobulins, Intravenous (1) · LHRH, Ac-Nal(1)-Cpa(2)-Trp(3)-Arg(6)-Ala(10)- (1) · LY2812223 (1) · Oxytocin (1) · Plasmapheresis (1) · Tacrolimus (1) · cetrorelix (1) · eculizumab (1) · sotrastaurin (1)
Merck KGaA, Darmstadt, Germany (2) · University of Ulm (2) · Brigham and Women's Hospital (1) · Mediti Pharma Inc. (1) · Novartis Pharmaceuticals (1) · OPKO Health, Inc. (1) · University of Sao Paulo General Hospital (1)
Spain (4) · United States (4) · Canada (3) · Germany (3) · United Kingdom (2) · Brazil (1) · France (1) · Italy (1) · Switzerland (1)
Anil K Chandraker, MD (1) · Helena P. Brentani, PHD (1)
2008 (1)